Can two genes control your destiny? Recently there’s been an explosion of genetic testing with 75,000 genetic tests on the market and 10 new tests entering the market daily. The business of clinical genomics is forecast to grow to a $7.7 billion global industry by 2020. But the testing of two genes--BRCA1 and BRCA2, which when mutated are known to greatly increase the risk of breast and ovarian cancer, as well as other cancers such as prostate, melanoma and pancreatic--were identified 25 years ago. Like eye or hair color, there’s 50 percent chance of inheriting a mutation from either parent.
New science and technology are continually changing the landscape for mutation carriers and now the Lawrence Family JCC, Jacobs Family Campus in La Jolla is teaming up with the Basser Center for BRCA at the University of Pennsylvania on July 17 for a panel discussion, Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk. Says Robyn Cohen, the JCC’s sports and fitness director, "The JCC is more than a fitness center. We are truly committed to the health and wellness of our community and are proud to partner with Basser to bring this exciting program and cutting-edge information to Southern California."
Panelists Susan Domchek MD, executive director of Penn Medicine’s Basser Center for BRCA, Paul Hyde, MD, Scripps Hospital breast surgeon, David Smotrich, MD, medical director of La Jolla IVF, Lisa Madlensky, PhD, director of the Family Cancer Genetics Program at Moores UCSD Cancer Center, and a local BRCA mutation carrier will meet to engage in a meaningful and important discussion, bringing education and awareness to the San Diego community.
The event will be held Tuesday, July 17, from 7-8:30 p.m. Meet & Greet panelists and attend a Resource Fair from 8:30-9 p.m. Free and open to the public with registration. Light refreshments to be served.
Register: www.lfjcc.org/brca or by calling 858-362-1348.
Event location: David & Dorothea Garfield Theatre, Lawrence Family JCC: 4126 Executive Dr, La Jolla, CA 92037.